Asian‐Pacific consensus statement on the management of chronic hepatitis B: An update*
Open Access
- 26 February 2003
- journal article
- review article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 18 (3) , 239-245
- https://doi.org/10.1046/j.1440-1746.2003.03037.x
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Is it safe to stop lamivudine after the emergence of YMDD mutants during lamivudine therapy for chronic hepatitis B?Journal of Hepatology, 2002
- Lack of emerging resistance mutations in 467 HBeAg− and HBeAg+ patients with chronic hepatitis B receiving Adefovir Dipivoxil for 48 weeksJournal of Hepatology, 2002
- Varied assembly and RNA editing efficiencies between genotypes I and II hepatitis D virus and their implicationsHepatology, 2002
- Protein Kinase C-Dependent Distribution of the Multidrug Resistance Protein 2 From the Canalicular to the Basolateral Membrane in Human Hepg2 CellsHepatology, 2001
- Consensus statements on the prevention and management of hepatitis B and hepatitis C in the Asia–Pacific region 1Journal of Gastroenterology and Hepatology, 2000
- Lamivudine as Initial Treatment for Chronic Hepatitis B in the United StatesNew England Journal of Medicine, 1999
- Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapyHepatology, 1999
- Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis BJournal of Hepatology, 1996
- Hepatitis G and other viral hepatitisHepatology, 1995